Reuters logo
BRIEF-Creso Pharma posts HY net loss attributable $3.5 million
August 28, 2017 / 12:20 AM / 2 months ago

BRIEF-Creso Pharma posts HY net loss attributable $3.5 million

Aug 28 (Reuters) - Creso Pharma Ltd

* HY net loss attributable to members $3.5 million versus loss of $493,426 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below